Chester County News and Community Website
MALVERN, PA — Almirall announced that the U.S. Food and Drug Administration (FDA) recently approved an expansion for its drug Klisyri, allowing it to be used over a larger surface …
FDA Approves Expanded Use for Almirall’s Klisyri in Actinic Keratosis Treatment Read More
WASHINGTON, D.C. — Syphilis rates in the United States have surged over the past decade, affecting all populations. In response, the Department of Health and Human Services (HHS) has formed …
HHS Task Force Addresses Rising Syphilis Rates with New Testing Guidelines Read More
PLYMOUTH MEETING, PA — A clinical evidence assessment by ECRI, a global patient safety organization, found that cranial electrical stimulation (CES) can effectively relieve anxiety symptoms. The treatment outperformed placebo …
Study Finds Cranial Electrical Stimulation Effective for Anxiety Relief Read More
PLYMOUTH MEETING, PA — New research published in the June 2024 issue of the Journal of the National Comprehensive Cancer Network (JNCCN) highlights a promising approach to improving the well-being …
Positive Psychology Program Shows Promise for Blood Cancer Patients Post-Transplant Read More
WASHINGTON, D.C. — The Centers for Disease Control and Prevention (CDC) has issued a warning about a multistate outbreak of Salmonella infections connected to bearded dragons. The outbreak has affected …
CDC Warns of Salmonella Outbreak Linked to Bearded Dragons Read More
WASHINGTON, D.C. — On Thursday, the Food and Drug Administration granted accelerated approval to repotrectinib (AUGTYRO), a new drug for treating certain advanced solid tumors in patients aged 12 and …
FDA Grants Accelerated Approval for New Cancer Drug Repotrectinib Read More
WASHINGTON, D.C. — The FDA on Thursday updated its recommendations for manufacturers of COVID-19 vaccines for the 2024-2025 season. The agency now advises that vaccines should target the KP.2 strain …
FDA Updates COVID-19 Vaccine Guidance to Target New Strain Read More
WASHINGTON, D.C. — The FDA on Wednesday granted full approval to the drug selpercatinib, marketed as Retevmo, for treating advanced thyroid cancer in both adults and children aged 2 and …
FDA Grants Full Approval to Retevmo for Advanced Thyroid Cancer Read More
WASHINGTON, D.C. — The FDA on Tuesday approved phenylpropanolamine hydrochloride chewable tablets for the control of urinary incontinence in dogs. This is the first generic version of these tablets, which …
FDA Approves Generic Chewable Tablets for Dog Incontinence Read More
WASHINGTON, D.C. — On Monday, the Food and Drug Administration (FDA) approved Iqirvo (elafibranor) oral tablets to treat primary biliary cholangitis (PBC). This rare autoimmune disease causes inflammation and damage …
FDA Approves New Treatment for Rare Liver Disease Read More